Company Overview of Vaxine Pty Ltd
Vaxine Pty Ltd., a biotechnology company, focuses on the development and commercialization of vaccines. Its human candidates include vaccines against seasonal and pandemic influenza, hepatitis B, Japanese encephalitis, West Nile virus, malaria, rabies, and allergy. The company also develops and commercializes vaccine adjuvants tailored to specific animal health problems. Its lead product Advax is an adjuvanted recombinant H1N1/2009 (swine flu) vaccine. Vaxine Pty Ltd. was founded in 2002 and is based in Adelaide, Australia.
Flinders Medical Centre
Adelaide, SA 5042
Founded in 2002
61 8 8204 4572
61 8 8204 5987
Key Executives for Vaxine Pty Ltd
Vaxine Pty Ltd Key Developments
Similar Private Companies By Industry
|AbRegen Pty Ltd.||Asia|
|Advanced Wound Care Pty Ltd.||Asia|
|Agriliance Pty Ltd.||Asia|
|AION Diagnostics Limited||Asia|
|Aquaceutics Pty Ltd||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vaxine Pty Ltd, please visit www.vaxine.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.